A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis

Vaccine

Volumn 23, Issue 30, 2005, Pages 3957-3960

  Liu, Yao Lung ^a   Kao, Min Tsung ^a   Huang, Chiu Ching ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

End stage renal disease (ESRD); Hemodialysis (HD); Hepatitis B vaccination; Peritoneal dialysis (PD)

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DELTOID MUSCLE; DOSE RESPONSE; FEMALE; FOLLOW UP; HEMODIALYSIS; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SEROCONVERSION; STATISTICAL SIGNIFICANCE; VACCINATION;

AGED; FEMALE; FOLLOW-UP STUDIES; HEPATITIS ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL DIALYSIS; VACCINATION;

EID: 19444380447     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.02.033     Document Type: Article

References (22)

1. R. Peces, M. de la Torre, R. Alcazar, and J.M. Urra Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients Am J Kidney Dis 29 1997 239 245
2. D. Docci, P.A. Cipolloni, S. Mengozzi, L. Baldrati, C. Capponcini, and C. Feletti Immunogenicity of a recombinant hepatitis B vaccine in hemodialysis patients: A 2-year follow-up Nephron 61 1992 352 353
3. H. Kohler, W. Arnold, G. Renschin, H.H. Dorneyer, Z. Meyer, and K.H. Buscgenfelde Active hepatitis B vaccination of dialysis patients and medical staff Kidney Int 25 1984 124 128
4. K. Bel'eed, M. Wright, D. Eadington, M. Farr, and L. Sellars Vaccination against hepatitis B infection in patients with end-stage renal disease Postagrad Med J 78 2002 538 540
5. A.N. Khan, J. Bernardini, R.M. Rault, and B. Piraino Low seroconversion with hepatitis B vaccination in peritoneal dialysis patients Perit Dial Int 16 1996 370 373
6. A. Mitwalli Responsiveness to hepatitis B vaccine in immunocompromised patients by doubling the dose scheduling Nephron 73 1996 417 420
7. K.F. Chau, Y.L. Cheng, D.N. Tsang, K.S. Choi, K.M. Wong, and W.L. Chak Efficacy and side effects of intradermal Hepatitis B vaccination in CAPD patients: a comparison with the intramuscular vaccination Am J Kidney Dis 43 2004 920 927
8. F. Giacchino, F. Quarello, Pellerey, and G. Piccoli Continuous ambulatory peritoneal dialysis improves immunodeficiency in uremic patients Nephron 35 1983 209 210
9. J.L. Touraine, F. Touraine, J.P. Revillard, J. Brochier, and J. Traeger T lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency Nephron 14 1975 195 208
10. J. Navarro, J.L. Touraine, C. Corre, and J. Traeger Prolongation of skin allograft survival and inhibition of graft versus host reaction in rodents treated with middle molecules Clin Immunol 31 1977 349 354
11. R.P. Popovich, J.W. Moncrief, K.D. Nolph, A.J. Ghods, Z.J. Twardowski, and W.K. Pyle Continuous ambulatory peritoneal dialysis Ann Intern Med 88 1978 448 452
12. Centers for Disease Control and Prevention (CDC). Recommendations for preventing transmissions of infectious diseases among chronic hemodialysis patients. MMWR 2001; 50:1-43.
13. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000. Am J Kidney Dis 2001;37(1 Suppl. 1):S7-S64.
14. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000. Am J Kidney Dis 2001;37(1 Suppl. 1):S65-S136.
15. J.F. Navarro, J.L. Teruel, M. Mateos, and J. Ortuno Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients Clin Nephrol 41 1994 113 116
16. R.W. Steketee, M.E. Ziarnik, and J.P. Davis Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin Am J Epidemiol 127 1988 772 782
17. R.C. Wood, K.L. MacDonald, K.E. White, C.W. Hedberg, M. Hanson, and M.T. Osterholm Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers JAMA 270 1993 2935 2939
18. A.L. Marangi, R. Giordano, A. Montanaro, F. De Padova, M.G. Schiavone, and G. Dongiovanni Hepatitis B virus infection in chronic uremia: long-term follow-up of a two-step integrated protocol of vaccination Am J Kidney Dis 23 1994 527 542
19. K. El Reshaid, S. Al Mufti, K.V. Johny, and T.N. Sugathan Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients Vaccine 12 1994 223 234
20. E. Egea, A. Iglesias, M. Salazar, C. Morimoto, M.S. Kruskall, and Z. Awdeh The cellular basis for lack of antibody response to hepatitis B vaccine in humans J Exp Med 173 1991 531 538
21. H. Dumann, S. Meuer, K.H. Meyer zum Buschenfelde, and H. Kohler Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure Kidney Int 38 1990 1164 1168
22. Centers for Disease Control and Prevention (CDC). Prevention and Control of Infections with Hepatitis Viruses in Correctional Settings. MMWR 2003;52:1-33.